The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Sees Significant Drop in Short Interest

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the recipient of a significant decline in short interest during the month of February. As of February 15th, there was short interest totalling 11,500 shares, a decline of 51.1% from the January 31st total of 23,500 shares. Based on an average daily volume of 31,500 shares, the days-to-cover ratio is currently 0.4 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Trading Up 0.3 %

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 stock opened at $18.03 on Friday. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 52 week low of $17.48 and a 52 week high of $20.85. The firm’s 50-day simple moving average is $18.16 and its 200 day simple moving average is $19.06.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Saturday, February 15th. Shareholders of record on Saturday, February 1st were issued a $0.2891 dividend. This represents a $1.16 annualized dividend and a dividend yield of 6.41%. The ex-dividend date of this dividend was Friday, January 31st. This is an increase from Carlyle Group Inc. 4.625% Subordinated Notes due 2061’s previous quarterly dividend of $0.29.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.